Efficacy and Safety Profile of CPX-351 in Secondary Acute Myeloid Leukemia (sAML): A Systematic Review

被引：0
|
作者：
Ibrahim, Ahmed [1 ]
Yousaf, Muhammad Abdullah [1 ]
Ikram, Mariam [2 ]
Khalid, Huma
Anum [3 ]
Safdar, Omar A. [4 ]
Anwer, Zain [5 ]
Faraz, Fatima [1 ]
Rehman, Mohammad [1 ]
Saad, Muhammad [2 ]
机构：
[1] Rawalpindi Med Univ, Rawalpindi, Pakistan
[2] Shifa Int Hosp Ltd, Islamabad, Pakistan
[3] Faisalabad Med Univ, Faisalabad, Pakistan
[4] Univ Arizona, Tucson, AZ USA
[5] Cleveland Clin, Cleveland, OH USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-187301
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Safety and efficacy of CPX-351 in younger patients (<60 years old) with secondary acute myeloid leukemia
    Przespolewski, Amanda
    Goldberg, Aaron D.
    Talati, Chetasi
    Fazal, Salman
    Vachhani, Pankit
    Sanikommu, Srinivasa R.
    Thota, Swapna
    Waksal, Julian
    Ball, Brian
    Famulare, Christopher
    Stahl, Maximilian
    Baron, Jeffrey
    Griffiths, Elizabeth A.
    Thompson, James E.
    Sweet, Kendra
    Wang, Eunice S.
    BLOOD, 2023, 141 (12) : 1489 - 1493
  • [2] CPX-351 TREATMENT IN SECONDARY ACUTE MYELOID LEUKEMIA (SAML): THE REAL LIFE EXPERIENCE FROM THE "ITALIAN TRIVENETO REGISTRY"
    Fili, C.
    Candoni, A.
    Mauro, E.
    Scattolin, A. M.
    Leoncin, M.
    Gurrieri, C.
    Nadali, G.
    Mosna, F.
    Michieli, M. G.
    Lico, A.
    Lazzarotto, D.
    Zannier, M. E.
    Simeone, E.
    Facchin, G.
    Battaglia, G.
    Gherlinzoni, F.
    Bassan, R.
    Semenzato, G.
    Fanin, R.
    HAEMATOLOGICA, 2021, 106 (10) : 128 - 129
  • [3] Safety and Efficacy of CPX-351 in Younger Patients < 60 Years Old with Secondary Acute Myeloid Leukemia: An Updated Analysis
    Przespolewski, Amanda
    Goldberg, Aaron D.
    Talati, Chetasi
    Fazal, Salman
    Vachhani, Pankit
    Sanikommu, Srinivasa Reddy R.
    Thota, Swapna
    Waksal, Julian
    Ball, Brian
    Famulare, Christopher
    Stahl, Maximilian
    Mckinnell, Zoe
    Baron, Jeffrey
    Griffiths, Elizabeth A.
    Thompson, James E.
    Sweet, Kendra
    Wang, Eunice S.
    BLOOD, 2021, 138
  • [4] CPX-351: changing the landscape of treatment for patients with secondary acute myeloid leukemia
    Talati, Chetasi
    Lancet, Jeffrey E.
    FUTURE ONCOLOGY, 2018, 14 (12) : 1147 - 1154
  • [5] Final Safety and Efficacy Results from the CPX-351 Early Access Program (EAP) for Older Patients with High-Risk/Secondary Acute Myeloid Leukemia (sAML)
    Roboz, Gail J.
    Larson, Melissa L.
    Rubenstein, S. Eric
    Solomon, Scott R.
    Schiller, Gary J.
    An, Qi
    Mancino, Emaryn
    Chiarella, Michael
    Louie, Arthur C.
    Lin, Tara L.
    BLOOD, 2018, 132
  • [6] Safety and efficacy of CPX-351 in younger patients &lt; 60 years old with secondary acute myeloid leukemia:An updated analysis
    Przespolewski, Amanda Cecile
    Talati, Chetasi
    Fazal, Salman
    Vachhani, Pankit
    Sanikommu, Srinivasa
    Thota, Swapna
    Baron, Jeffrey
    Griffiths, Elizabeth A.
    Thompson, James E.
    Sweet, Kendra Lynn
    Wang, Eunice S.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [7] Safety and Efficacy of Liposomal Cytarabine/Daunorubicin (CPX-351) in Younger Patients &lt; 60 Years Old with Secondary Acute Myeloid Leukemia
    Przespolewski, Amanda
    Talati, Chetasi
    Vachhani, Pankit
    Sanikommu, Srinivasa Reddy
    Thota, Swapna
    Baron, Jeffrey
    Griffiths, Elizabeth A.
    Thompson, James E.
    Sweet, Kendra L.
    Wang, Eunice S.
    BLOOD, 2018, 132
  • [8] CPX-351 in FLT3-mutated acute myeloid leukemia
    Andrews, Claire
    Pullarkat, Vinod
    Recher, Christian
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [9] Liposomal cytarabine and daunorubicin (CPX-351) for treatment of acute myeloid leukemia
    Ronson, Aaron
    Tvito, Ariella
    Rowe, Jacob M.
    EXPERT OPINION ON ORPHAN DRUGS, 2017, 5 (04): : 369 - 374
  • [10] CPX-351 in acute myeloid leukemia: can a new formulation maximize the efficacy of old compounds?
    Brunetti, Claudia
    Anelli, Luisa
    Zagaria, Antonella
    Specchia, Giorgina
    Albano, Francesco
    EXPERT REVIEW OF HEMATOLOGY, 2017, 10 (10) : 853 - 862
12345